AAAAAA

   
Results: 1-14 |
Results: 14

Authors: VANDERMEER M DEBOER JAM HOMPES PGA SCHOEMAKER J
Citation: M. Vandermeer et al., OCTREOTIDE, A SOMATOSTATIN ANALOG, ALTERS OVARIAN SENSITIVITY TO GONADOTROPIN STIMULATION AS MEASURED BY THE FOLLICLE-STIMULATING-HORMONE THRESHOLD IN POLYCYSTIC-OVARY-SYNDROME, Human reproduction (Oxford. Print), 13(6), 1998, pp. 1465-1469

Authors: VANMONTFRANS JM VANHOOFF MHA HOMPES PGA LAMBALK CB
Citation: Jm. Vanmontfrans et al., TREATMENT OF HYPERINSULINEMIA IN POLYCYSTIC-OVARY-SYNDROME, Human reproduction, 13(1), 1998, pp. 5-6

Authors: VANDERMEER M HOMPES PGA DEBOER JAM SCHATS R SCHOEMAKER J
Citation: M. Vandermeer et al., COHORT SIZE RATHER THAN FOLLICLE-STIMULATING-HORMONE THRESHOLD LEVEL DETERMINES OVARIAN SENSITIVITY IN POLYCYSTIC-OVARY-SYNDROME, The Journal of clinical endocrinology and metabolism, 83(2), 1998, pp. 423-426

Authors: BROEKMANS FJ HEITBRINK MA HOMPES PGA SCHOUTE E FALKE T SCHOEMAKER J
Citation: Fj. Broekmans et al., QUANTITATIVE MRI OF UTERINE LEIOMYOMAS DURING TRIPTORELIN TREATMENT -REPRODUCIBILITY OF VOLUME ASSESSMENT AND PREDICTABILITY OF TREATMENT RESPONSE, Magnetic resonance imaging, 14(10), 1996, pp. 1127-1135

Authors: SCHEELE F HOMPES PGA LAMBALK CB SCHOUTE E BROEKMANS FJ SCHOEMAKER J
Citation: F. Scheele et al., THE GNRH CHALLENGE TEST - A QUANTITATIVE MEASURE OF PITUITARY DESENSITIZATION DURING GNRH AGONIST ADMINISTRATION, Clinical endocrinology, 44(5), 1996, pp. 581-586

Authors: BROEKMANS FJ HOMPES PGA LAMBALK CB SCHOUTE E BROEDERS A SCHOEMAKER J
Citation: Fj. Broekmans et al., SHORT-TERM PITUITARY DESENSITIZATION - EFFECTS OF DIFFERENT DOSES OF THE GONADOTROPIN-RELEASING-HORMONE AGONIST TRIPTORELIN, Human reproduction, 11(1), 1996, pp. 55-60

Authors: VANDERMEER M HOMPES PGA SCHEELE F SCHOUTE E POPPSNIJDERS C SCHOEMAKER J
Citation: M. Vandermeer et al., THE IMPORTANCE OF ENDOGENOUS FEEDBACK FOR MONOFOLLICULAR GROWTH IN LOW-DOSE STEP-UP OVULATION INDUCTION WITH FOLLICLE-STIMULATING-HORMONE IN POLYCYSTIC-OVARY-SYNDROME - A RANDOMIZED STUDY, Fertility and sterility, 66(4), 1996, pp. 571-576

Authors: HOMPES PGA KONINCKX PR KENNEDY S VANKAMP GF VERSTRAETEN RA CORNILLIE F
Citation: Pga. Hompes et al., SERUM CA-125 CONCENTRATIONS DURING MIDFOLLICULAR PHASE, A CLINICALLY USEFUL AND REPRODUCIBLE MARKER IN DIAGNOSIS OF ADVANCED ENDOMETRIOSIS, Clinical chemistry, 42(11), 1996, pp. 1871-1874

Authors: BROEKMANS FJ HOMPES PGA HEITBRINK MA NETELENBOS CC ROOS JC FALKE TM SCHOEMAKER J
Citation: Fj. Broekmans et al., 2-STEP GONADOTROPIN-RELEASING-HORMONE AGONIST TREATMENT OF UTERINE LEIOMYOMAS - STANDARD-DOSE THERAPY FOLLOWED BY REDUCED-DOSE THERAPY, American journal of obstetrics and gynecology, 175(5), 1996, pp. 1208-1216

Authors: SCHEELE F VANDERMEER M LAMBALK CB SCHOUTE E SCHOEMAKER J HOMPES PGA
Citation: F. Scheele et al., EXPLORING THE RECOVERY PHASE AFTER TREATMENT WITH A GONADOTROPIN-RELEASING HORMONE-AGONIST FOR OVULATION INDUCTION IN POLYCYSTIC-OVARY-SYNDROME - 3 PILOT TRIALS, European journal of obstetrics, gynecology, and reproductive biology, 62(2), 1995, pp. 221-224

Authors: VANDERMEER M HOMPES PGA SCHEELE F SCHOUTE E VEERSEMA S SCHOEMAKER J
Citation: M. Vandermeer et al., FOLLICLE-STIMULATING-HORMONE (FSH) DYNAMICS OF LOW-DOSE STEP-UP OVULATION INDUCTION WITH FSH IN PATIENTS WITH POLYCYSTIC-OVARY-SYNDROME, Human reproduction, 9(9), 1994, pp. 1612-1617

Authors: SCHEELE F HOMPES PGA VANDERMEER M SCHOUTE E SCHOEMAKER J
Citation: F. Scheele et al., THE EFFECTS OF A GONADOTROPIN-RELEASING-HORMONE AGONIST ON TREATMENT WITH LOW-DOSE FOLLICLE-STIMULATING-HORMONE IN POLYCYSTIC-OVARY-SYNDROME, Human reproduction, 8(5), 1993, pp. 699-704

Authors: SCHEELE F HOMPES PGA VANDERMEER M SCHOUTE E SCHOEMAKER J
Citation: F. Scheele et al., PULSATILE GONADOTROPIN-RELEASING-HORMONE STIMULATION AFTER MEDIUM-TERM PITUITARY SUPPRESSION IN POLYCYSTIC-OVARY-SYNDROME, Human reproduction, 8, 1993, pp. 197-199

Authors: SCHEELE F HOMPES PGA VANDERMEER M SCHOUTE E SCHOEMAKER J
Citation: F. Scheele et al., THE RELATIONSHIP BETWEEN FOLLICLE-STIMULATING-HORMONE DOSE AND LEVEL AND ITS RELEVANCE FOR OVULATION INDUCTION WITH ADJUVANT GONADOTROPIN-RELEASING HORMONE-AGONIST TREATMENT, Fertility and sterility, 60(4), 1993, pp. 620-625
Risultati: 1-14 |